APA
Guo S., Tang L., Chen Q., Zhang L., Liu L., Guo L., Mo H., Luo D., Huang P., Xiang Y., Sun R., Chen M., Wang L., Lv X., Zhao C., Guo X., Cao K., Qian C., Zeng M., Bei J., Hong M., Shao J., Sun Y., Ma J. & Mai H. (20180112). Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in stage III-IVb nasopharyngeal carcinoma patients with Epstein-Barr virus DNA ≥4000 copies/ml: a matched study. : Oncotarget.
Chicago
Guo Shan-Shan, Tang Lin-Quan, Chen Qiu-Yan, Zhang Lu, Liu Li-Ting, Guo Ling, Mo Hao-Yuan, Luo Dong-Hua, Huang Pei-Yu, Xiang Yan-Qun, Sun Rui, Chen Ming-Yuan, Wang Lin, Lv Xing, Zhao Chong, Guo Xiang, Cao Ka-Jia, Qian Chao-Nan, Zeng Mu-Shen, Bei Jin-Xin, Hong Ming-Huang, Shao Jian-Yong, Sun Ying, Ma Jun and Mai Hai-Qiang. 20180112. Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in stage III-IVb nasopharyngeal carcinoma patients with Epstein-Barr virus DNA ≥4000 copies/ml: a matched study. : Oncotarget.
Harvard
Guo S., Tang L., Chen Q., Zhang L., Liu L., Guo L., Mo H., Luo D., Huang P., Xiang Y., Sun R., Chen M., Wang L., Lv X., Zhao C., Guo X., Cao K., Qian C., Zeng M., Bei J., Hong M., Shao J., Sun Y., Ma J. and Mai H. (20180112). Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in stage III-IVb nasopharyngeal carcinoma patients with Epstein-Barr virus DNA ≥4000 copies/ml: a matched study. : Oncotarget.
MLA
Guo Shan-Shan, Tang Lin-Quan, Chen Qiu-Yan, Zhang Lu, Liu Li-Ting, Guo Ling, Mo Hao-Yuan, Luo Dong-Hua, Huang Pei-Yu, Xiang Yan-Qun, Sun Rui, Chen Ming-Yuan, Wang Lin, Lv Xing, Zhao Chong, Guo Xiang, Cao Ka-Jia, Qian Chao-Nan, Zeng Mu-Shen, Bei Jin-Xin, Hong Ming-Huang, Shao Jian-Yong, Sun Ying, Ma Jun and Mai Hai-Qiang. Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in stage III-IVb nasopharyngeal carcinoma patients with Epstein-Barr virus DNA ≥4000 copies/ml: a matched study. : Oncotarget. 20180112.